Nasdaq · Healthcare
Lite Strategy, Inc. (LITS)
As-reported financials and recent SEC filings for Lite Strategy, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$0
Net income
$-15.9M
Net margin
—
Diluted EPS
$-2.39
ROE
-94.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $65.3M | $48.8M | $40.7M | $34.8M |
| Gross profit | — | — | — | — | — |
| Operating income | $-17.5M | $14.5M | $-36.8M | $-75.5M | $-60.4M |
| Net income | $-15.9M | $17.8M | $-32.0M | $-54.0M | $-41.0M |
| Diluted EPS | $-2.39 | $2.67 | $-4.78 | $-9.99 | $-10.80 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-25
View on EDGAR →8-K2026-05-13
View on EDGAR →10-Q2026-05-13
View on EDGAR →8-K2026-02-17
View on EDGAR →10-Q2026-02-17
View on EDGAR →SCHEDULE 13G/A2026-02-17
View on EDGAR →42026-02-12
View on EDGAR →8-K2026-02-12
View on EDGAR →Largest Healthcare peers
Go deeper on LITS
Search Lite Strategy, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.